Bicycle Therapeutics plc (50BA) — Cash Flow-to-Debt Ratio
Bicycle Therapeutics plc (50BA) has a Cash Flow-to-Debt Ratio of -0.67x as of March 2026, meaning its operating cash flow of €-65.92 Million could theoretically repay -1% of its total liabilities (€98.08 Million) in one year. See Bicycle Therapeutics plc free cash flow ratio to measure how efficiently the company converts operating cash flow to free cash.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Bicycle Therapeutics plc Cash Flow-to-Debt Ratio (2018–2025)
Historical debt coverage capacity for Bicycle Therapeutics plc across 8 annual periods. Also explore Bicycle Therapeutics plc (50BA) net asset momentum to track the company's year-over-year net asset growth rate.
Annual Cash Flow-to-Debt Ratio for Bicycle Therapeutics plc (2018–2025)
Year-by-year debt coverage analysis for Bicycle Therapeutics plc. For market capitalisation and broader financial context, see Bicycle Therapeutics plc (50BA) market capitalisation.
| Year | CF-to-Debt Ratio | Operating CF (EUR) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | -2.32x | €-249.68 Million | €107.62 Million | ▼ -130.7% |
| 2024 | -1.01x | €-164.72 Million | €163.81 Million | ▼ -417.0% |
| 2023 | -0.19x | €-43.65 Million | €224.41 Million | ▲ +68.4% |
| 2022 | -0.62x | €-86.11 Million | €139.83 Million | ▼ -455.9% |
| 2021 | -0.11x | €-14.79 Million | €133.54 Million | ▲ +59.1% |
| 2020 | -0.27x | €-17.79 Million | €65.69 Million | ▲ +83.9% |
| 2019 | -1.68x | €-28.61 Million | €17.00 Million | ▼ -877.7% |
| 2018 | -0.17x | €-26.08 Million | €151.45 Million | — |